Biomarker discovery from we to me: Is learning from each patient a new approach?

Biomarker discovery from we to me: Is learning from each patient a new approach?
Clin Cancer Res. 2018 Mar 26;:
Authors: Lheureux S
Abstract
The immune response is a dynamic multistep process, with a complex system regulation. Identification of predictive biomarkers is therefore challenging. Deep investigation of an exceptional responder to pembrolizumab in ovarian cancer identifies new mechanism of response and highlights the power of individualized medicine strategy.
PMID: 29581132 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - March 26, 2018 Category: Cancer & Oncology Authors: Lheureux S Tags: Clin Cancer Res Source Type: research